Microbot Medical Inc. is among the best-performing NASDAQ stocks, securing a patent in China for its LIBERTY System. The system includes 9 global patents and 59 pending applications, focusing on minimally invasive endovascular robotic surgery. The company eyes a US launch in Q3 2025. Microbot Medical is a clinical-stage medical device company in Israel and the US, specializing in robotic endoluminal surgery devices. While MBOT shows investment potential, other AI stocks may offer greater upside with less risk. Check out the best short-term AI stock recommendations.

Read more at Yahoo Finance: Microbot Medical Secures China Patent for LIBERTY System, Eyes Q3 2025 US Launch